Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LAM RESEARCH CORP Director's Dealing 2025

Feb 6, 2025

29803_dirs_2025-02-06_6ef3a72b-d4b1-4d13-8549-704f5046a0a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LAM RESEARCH CORP (LRCX)
CIK: 0000707549
Period of Report: 2025-02-05

Reporting Person: ARCHER TIMOTHY (President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-05 Common Stock M 86548 Acquired 932940 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-05 Market-based Performance Restricted Stock Unit $0 M 152000 Disposed Common Stock (152000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 48026.049 Indirect
Common Stock 5670.281 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Market-based Performance Restricted Stock Unit $0 Common Stock (181020) 181020 Direct
Market-based Performance Restricted Stock Unit $0 Common Stock (147260) 147260 Direct
Employee Stock Option (Right to Buy) $54.057 2029-03-01 Common Stock (151980) 151980 Direct
Employee Stock Option (Right to Buy) $59.881 2028-03-01 Common Stock (59970) 59970 Direct
Employee Stock Option (Right to Buy) $49.092 2030-03-01 Common Stock (181020) 181020 Direct
Employee Stock Option (Right to Buy) $30.033 2027-03-02 Common Stock (121400) 121400 Direct
Employee Stock Option (Right to Buy) $17.675 2026-03-01 Common Stock (113300) 113300 Direct
Employee Stock Option (Right to Buy) $98.153 2031-03-01 Common Stock (147240) 147240 Direct

Footnotes

F1: On 03/01/2022, the Reporting Person received a target grant of 152,000 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 03/01/2025. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from 02/01/2022 through 01/31/2025.

F2: The amount reported includes shares subject to unvested restricted stock units.

F3: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2025. The performance of this award is based on the Lam Research Total Shareholder Return performance
relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2022 through 01/31/2025.

F4: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026.

F5: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2027. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2024 through 01/31/2027

F6: The stock options will become exercisable in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025.

F7: The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024.

F8: The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026.

F9: The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.

F10: The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022.

F11: The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.